These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 14529827)
1. Interleukin (IL)-21 and IL-15 genetic transfer synergistically augments therapeutic antitumor immunity and promotes regression of metastatic lymphoma. Kishida T; Asada H; Itokawa Y; Cui FD; Shin-Ya M; Gojo S; Yasutomi K; Ueda Y; Yamagishi H; Imanishi J; Mazda O Mol Ther; 2003 Oct; 8(4):552-8. PubMed ID: 14529827 [TBL] [Abstract][Full Text] [Related]
2. Interleukin-21 triggers both cellular and humoral immune responses leading to therapeutic antitumor effects against head and neck squamous cell carcinoma. Nakano H; Kishida T; Asada H; Shin-Ya M; Shinomiya T; Imanishi J; Shimada T; Nakai S; Takeuchi M; Hisa Y; Mazda O J Gene Med; 2006 Jan; 8(1):90-9. PubMed ID: 16097036 [TBL] [Abstract][Full Text] [Related]
3. Expression of IL-27 in murine carcinoma cells produces antitumor effects and induces protective immunity in inoculated host animals. Chiyo M; Shimozato O; Yu L; Kawamura K; Iizasa T; Fujisawa T; Tagawa M Int J Cancer; 2005 Jun; 115(3):437-42. PubMed ID: 15688376 [TBL] [Abstract][Full Text] [Related]
4. IL-21-Expressing Mesenchymal Stem Cells Prevent Lethal B-Cell Lymphoma Through Efficient Delivery of IL-21, Which Redirects the Immune System to Target the Tumor. Kim N; Nam YS; Im KI; Lim JY; Lee ES; Jeon YW; Cho SG Stem Cells Dev; 2015 Dec; 24(23):2808-21. PubMed ID: 26415081 [TBL] [Abstract][Full Text] [Related]
5. [Construction of recombinant plasmid pIRES-GM-CSF-IL-21 and its therapeutic effect on orthotopically transplanted liver cancer in mice]. Cheng MR; Li Q; Hong XW; Ye T; He B; Cheng ZJ; Xu HZ; Zha BB Zhonghua Zhong Liu Za Zhi; 2011 Sep; 33(9):661-5. PubMed ID: 22340045 [TBL] [Abstract][Full Text] [Related]
6. Electrochemo-gene therapy of cancer: intratumoral delivery of interleukin-12 gene and bleomycin synergistically induced therapeutic immunity and suppressed subcutaneous and metastatic melanomas in mice. Kishida T; Asada H; Itokawa Y; Yasutomi K; Shin-Ya M; Gojo S; Cui FD; Ueda Y; Yamagishi H; Imanishi J; Mazda O Mol Ther; 2003 Nov; 8(5):738-45. PubMed ID: 14599806 [TBL] [Abstract][Full Text] [Related]
7. Antitumor and antimetastatic activity of interleukin 12 against murine tumors. Brunda MJ; Luistro L; Warrier RR; Wright RB; Hubbard BR; Murphy M; Wolf SF; Gately MK J Exp Med; 1993 Oct; 178(4):1223-30. PubMed ID: 8104230 [TBL] [Abstract][Full Text] [Related]
8. Interleukin-12 administration is more effective for preventing metastasis than for inhibiting primary established tumors in a murine model of spontaneous hepatic metastasis. Kobayashi T; Shiiba K; Satoh M; Hashimoto W; Mizoi T; Matsuno S; Takeda K Surg Today; 2002; 32(3):236-42. PubMed ID: 11991509 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of colon tumor growth by IL-15 immunogene therapy. He X; Li W; Wang Y; Hou L; Zhu L Mol Med Rep; 2012 Jan; 5(1):96-102. PubMed ID: 21956355 [TBL] [Abstract][Full Text] [Related]
10. Expression of the interleukin-21 gene in murine colon carcinoma cells generates systemic immunity in the inoculated hosts. Ugai S; Shimozato O; Kawamura K; Wang YQ; Yamaguchi T; Saisho H; Sakiyama S; Tagawa M Cancer Gene Ther; 2003 Mar; 10(3):187-92. PubMed ID: 12637939 [TBL] [Abstract][Full Text] [Related]
11. [Antitumoral efficacy by systemic delivery of cationic liposome-plasmid interleukin-15 complexes in murine models of lung metastasis]. Teng X; Zhou XK; Zhang YB; Qiu J; Mao YQ; Deng HX; Li J Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Feb; 28(2):148-52. PubMed ID: 22304773 [TBL] [Abstract][Full Text] [Related]
12. In vivo antitumor activity of interleukin 21 mediated by natural killer cells. Wang G; Tschoi M; Spolski R; Lou Y; Ozaki K; Feng C; Kim G; Leonard WJ; Hwu P Cancer Res; 2003 Dec; 63(24):9016-22. PubMed ID: 14695220 [TBL] [Abstract][Full Text] [Related]
13. IL-27 mediates complete regression of orthotopic primary and metastatic murine neuroblastoma tumors: role for CD8+ T cells. Salcedo R; Stauffer JK; Lincoln E; Back TC; Hixon JA; Hahn C; Shafer-Weaver K; Malyguine A; Kastelein R; Wigginton JM J Immunol; 2004 Dec; 173(12):7170-82. PubMed ID: 15585838 [TBL] [Abstract][Full Text] [Related]